Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

10 Results

Guidelines and Advice

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Status: Archived
ID: 7-4
Version: 2

Dec 2017

Guidelines and Advice

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Status: Archived
ID: 12-3

Jan 2003

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Status: Archived
ID: 2-16b
Version: 2

Sep 2011

Guidelines and Advice

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Status: Archived
ID: 2-17

Sep 2011

Guidelines and Advice

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Status: Archived
ID: 3-12

Nov 2011

Guidelines and Advice

Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Status: Archived
ID: 3-2-1

Oct 2012

Guidelines and Advice

Use of Neoadjuvant Chemotherapy in Transitional Cell Carcinoma of the Bladder

Status: Archived
ID: 3-2-2 Version 2
Version: 2

Nov 2012

Guidelines and Advice

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022